Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants

Biology of the Neonate

Volumn 76, Issue 4, 1999, Pages 207-213

  Poets, Christian F ^a   Darraj, Sandra ^a   Bohnhorst, Bettina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apnoea of prematurity; Arterial oxygen saturation; Respiratory stimulants

Indexed keywords

CAFFEINE; DOXAPRAM; RESPIRATORY STIMULANT AGENT;

APNEA; ARTERIAL OXYGEN SATURATION; ARTICLE; BRADYCARDIA; BREATHING MECHANICS; CLINICAL ARTICLE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HUMAN; HYPOXEMIA; INFANT; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; NOSE AIRFLOW; ORAL DRUG ADMINISTRATION; PREMATURITY; PRIORITY JOURNAL; PULSE OXIMETER; WAKEFULNESS; WAVEFORM;

ANOXEMIA; APNEA; BIRTH WEIGHT; BRADYCARDIA; CAFFEINE; DOXAPRAM; DRUG RESISTANCE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFUSIONS, INTRAVENOUS; INTUBATION, GASTROINTESTINAL; OXYGEN; RESPIRATORY SYSTEM AGENTS;

EID: 0032850642     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014160     Document Type: Article

References (25)

1. Poets CF, Sens B: Changes in intubation rates and outcome of very low birth weight infants: A population-based study. Pediatrics 1996; 98:24-27.
2. Samuels MP, Southall DP: Recurrent apnea; in Sinclair JC, Brackan MB (eds): Effective Care of the Newborn Infant. Oxford, Oxford University Press, 1992, pp 385-397.
3. Bucher HU, Duc G: Does caffeine prevent hypoxaemic episodes in premature infants? Eur J Pediatr 1988;147:288-291.
4. Alpan G, Eyal F, Sagi E, Springer C, Patz D, Goder K: Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline. J Pediatr 1984;104:634-637.
5. Bairam A, Faulon M, Monin P, Vert P: Doxapram for the initial treatment of idiopathic apnea of prematurity. Biol Neonate 1992;61:209-213.
6. Barrington KJ, Finer NN, Torok-Both G, Jamali F, Coutts RT: Dose-response relationship of doxapram in the therapy for refractory apnea of prematurity. Pediatrics 1987;80: 22-27.
7. Eyal F, Alpan G, Sagi E, Glick B, Peleg O, Dgani Y, Arad I: Aminophylline versus doxapram in idiopathic apnea of prematurity: A double-blind controlled study. Pediatrics 1985;75:709-713.
8. Hayakawa F, Hakamada S, Kuno K, Nakashima T, Miyachi Y: Doxapram in the treatment of idiopathic apnea of prematurity: Desirable dosage and serum concentrations. J Pediatr 1986;109:138-140.
9. Peliowski A, Finer NN: A blinded, randomized, placebo-controlled trail to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr 1990; 116:648-653.
10. Sagi E, Eyal F, Alpan G, Patz D, Arad I: Idiopathic apnoea of prematurity treated with doxapram and aminophylline. Arch Dis Child 1984;59:281-283.
11. Tay-Uyboco J, Kwiatkowski K, Gates DB, Seifert B, Hasan SU, Rigatto H: Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 1991;59:190-200.
12. Bairam A, Akramoff-Gershan L, Beharry K, Laudignon N, Papageorgiou A, Aranda JV: Gastrointestinal absorption of doxapram in neonates. Am J Perinatal 1991;8:110-113.
13. Romeo MG, Betta P, Tina LG, Cilauro S, Saporito A, DiStefano G: Oral administration of doxapram in preterm neonates with aminophylline-resistant apnea crisis. Pediatr Med Chir 1995;17:123-126.
14. Poets CF: Apnoen bei Frühgeborenen: Epidemiologie. Pathophysiologie und Präventionsmöglichkeiten. Monatsschr Kinderheilkd 1993; 141:558-566.
15. Anders T, Emde R, Parmelee A: A manual of standardized terminology techniques and criteria for scoring of states of sleep and wakefulness in newborn infants. Los Angeles, UCLA Brain Information Service, 1971, pp 1-24.
16. Stebbens VA, Poets CF, Alexander JR, Arrowsmith WA, Southall DP: Oxygen saturation and breathing patterns in infancy. I. Full-term infants in the second month of life. Arch Dis Child 1991;66:569-573.
17. Poets CF, Pauls U, Bohnhorst B: Effect of blood transfusion on apnea, bradycardia and hypoxemia in preterm infants. Eur J Pediatr 1997; 156:311-316.
18. De Villiers GS, Walele A, van der Merwe PL, Kalis NN: Second-degree atrioventricular heart block after doxapram administration. J Pediatr 1998;133:149-150.
19. Blanchard PW, Aranda JV: Pharmacotherapy of respiratory control disorders; in Beckerman RC, Brouillette RT, Hunt CE (eds): Respiratory Control Disorders in Infants and Children. Baltimore, Williams & Wilkins, 1992, pp 352-370.
20. Barrington KJ, Finer NN, Peters KL, Barton J: Physiologic effects of doxapram in idiopathic apnca of prematurity. J Pediatr 1986;108: 125-129.
21. Côté A, Blanchard PW, Meehan B: Metabolic and cardiorespiratory effects of doxapram and theophylline in sleeping newborn piglets. J Appl Physiol 1992;72:410-415.
22. Tappin DM, Ford RPK, Nelson KP, Price B, Macey PM, Dove R, Larkin J, Slade B: Breathing, sleep state, and rectal temperature oscillations. Arch Dis Child 1996;74:427-431.
23. Thoman EB, Davis DH, Raye JR, Phillips AF, Rowe JC, Denenberg VH: Theophylline affects sleep-wake state development in preterm infants. Neuropediatrics 1985;16: 13-18.
24. Poets CF, Stebbens VA, Alexander JR, Arrowsmith WA, Salfield SAW, Southall DP: Arterial oxygen saturation in preterm infants at discharge from the hospital and 6 weeks later. J Pediatr 1992;120:447-454.
25. Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin. Leitlinien zur Therapie der Apnoe-Anfälle bei Frühgeborenen. http:/ www.uni-duesseldorf.de/www/ awmf/leitlinien.